Last reviewed · How we verify

NCT03263169

Community-based Personalized Care and QOL

Status unknown Last updated 28 August 2017
What this trial tests

trial testing Community-based personalized care in Aging in 1,100 participants. Status unknown.

Timeline
1 July 2017
Primary endpoint
30 September 2018
30 September 2018

Quick facts

Lead sponsorWindsor-Essex Compassionate Care Community
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,100
Start date1 July 2017
Primary completion30 September 2018
Estimated completion30 September 2018
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Windsor-Essex Compassionate Care Community

Who can join

65 and older, any sex, with Aging or Disability or Chronic Disease Leading to Disablement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A pragmatic randomized trial to evaluate the impact of an integrated patient experience and outcome measurement system supported by citizens, caregivers and community through eHealth technology. The primary research question is: What is the effectiveness of the WECCC approach on quality of life in people aged 65 and older or who self-identify as disabled compared to people not receiving the Health TAPESTRY program?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Windsor-Essex Compassionate Care Community trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03263169.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing